S'abonner

Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling - 18/04/17

Doi : 10.1016/j.jaci.2016.08.029 
David A. Ewald, MSc a, b, c, , Shinji Noda, MD, PhD a, , Margeaux Oliva, BA d, Thomas Litman, PhD b, e, Saeko Nakajima, MD, PhD f, Xuan Li, MSc a, Hui Xu, MSc d, Christopher T. Workman, PhD c, Peter Scheipers, PhD b, Naila Svitacheva, PhD g, Tord Labuda, PhD h, James G. Krueger, MD, PhD a, Mayte Suárez-Fariñas, PhD a, i, Kenji Kabashima, MD, PhD f, j, , Emma Guttman-Yassky, MD, PhD a, d, ,
a Laboratory for Investigative Dermatology, Rockefeller University, New York, NY 
b Exploratory Biology, LEO Pharma A/S, Ballerup, Denmark 
c Regulatory Genomics, Integrative Systems Biology, Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kgs. Lyngby, Denmark 
d Department of Dermatology and the Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 
i Department of Dermatology, the Departments of Population Health Science and Policy, and the Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 
e Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark 
f Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan 
g In Vivo Biology, LEO Pharma A/S, Ballerup, Denmark 
h Translational Medicine, LEO Pharma A/S, Ballerup, Denmark 
j Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore 

Corresponding author: Emma Guttman-Yassky, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.Department of DermatologyIcahn School of Medicine at Mount Sinai Medical Center5 E 98th StNew YorkNY10029

Abstract

Background

Atopic dermatitis (AD) is caused by a complex interplay between immune and barrier abnormalities. Murine models of AD are essential for preclinical assessments of new treatments. Although many models have been used to simulate AD, their transcriptomic profiles are not fully understood, and a comparison of these models with the human AD transcriptomic fingerprint is lacking.

Objective

We sought to evaluate the transcriptomic profiles of 6 common murine models and determine how they relate to human AD skin.

Methods

Transcriptomic profiling was performed by using microarrays and quantitative RT-PCR on biopsy specimens from NC/Nga, flaky tail, Flg-mutated, ovalbumin-challenged, oxazolone-challenged, and IL-23–injected mice. Gene expression data of patients with AD, psoriasis, and contact dermatitis were obtained from previous patient cohorts. Criteria of a fold change of 2 or greater and a false discovery rate of 0.05 or less were used for gene arrays.

Results

IL-23–injected, NC/Nga, and oxazolone-challenged mice show the largest homology with our human meta-analysis–derived AD transcriptome (37%, 18%, 17%, respectively). Similar to human AD, robust TH1, TH2, and also TH17 activation are seen in IL-23–injected and NC/Nga mice, with similar but weaker inflammation in ovalbumin-challenged mice. Oxazolone-challenged mice show a TH1-centered reaction, and flaky tail mice demonstrate a strong TH17 polarization. Flg-mutated mice display filaggrin downregulation without significant inflammation.

Conclusion

No single murine model fully captures all aspects of the AD profile; instead, each model reflects different immune or barrier disease aspects. Overall, among the 6 murine models, IL-23–injected mice best simulate human AD; still, the translational focus of the investigation should determine which model is most applicable.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, TH1, TH2, TH17, psoriasis, contact dermatitis, mouse model, NC/Nga, filaggrin, oxazolone, ovalbumin, IL-2

Abbreviations used : AD, CD, CLDN8, Ct, DEG, FCH, FDR, FLG, LOR, MADAD, OVA, OXA, TLDA


Plan


 Supported by a research grant (to E.G.-Y.) from LEO Pharma A/S. S.N., M.S.-F., and J.G.K. were supported by grant no. 5UL1RR024143-02 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. D.A.E. is partly funded by the Danish Ministry of Science and Higher Education.
 Disclosure of potential conflict of interest: D. A. Ewald is an employee of Leo Pharma A/S. S. Noda receives grant support from the CTSA program. N. Svitacheva is an employee of Leo Pharma A/S. T. Labuda is an employee of Leo Pharma A/S. J. G. Krueger reports grants paid to his institution and personal fees from Novartis, Pfizer, Janssen, Lilly, Merck, Kadmon, Dermira, Boehringer, BMS, and Paraxel during the conduct of the study; grants paid to his institution from Amgen, Innovaderm and Kyowa; and personal fees from Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Xenoport, and Kineta. E. Guttman-Yassky serves on the board for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, and Leo Pharma; serves as a consultant for Regeneron, Sanofi Aventis, MedImmune, Celgene, Steifel/GlaxoSmithKline, Celsus, BMS, Amgen and Drais; and receives grant support from Regeneron, Celgene, BMS and Janssen. The rest of the authors declare that they have no relevant conflicts of interest.


© 2016  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 139 - N° 2

P. 562-571 - février 2017 Retour au numéro
Article précédent Article précédent
  • MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis
  • Ankit Srivastava, Pernilla Nikamo, Warangkana Lohcharoenkal, Dongqing Li, Florian Meisgen, Ning Xu Landén, Mona Ståhle, Andor Pivarcsi, Enikö Sonkoly
| Article suivant Article suivant
  • Humoral and cellular responses to casein in patients with food protein–induced enterocolitis to cow's milk
  • Jean Christoph Caubet, Ramon Bencharitiwong, Andrew Ross, Hugh A. Sampson, M. Cecilia Berin, Anna Nowak-W?grzyn

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.